## Anti-dsDNA Antibodies in SLE Nephritis **Key Point:** Anti-dsDNA (anti-double-stranded DNA) antibodies are the most specific autoantibodies for SLE and show the strongest association with lupus nephritis. ### Clinical Significance **High-Yield:** Anti-dsDNA antibodies are found in 60–70% of SLE patients and correlate with: - Active lupus nephritis (present in >90% of patients with proliferative glomerulonephritis) - Disease activity and flares - Worse renal outcomes, particularly in Class III and IV nephritis - Circulating immune complex formation ### Mechanism Anti-dsDNA antibodies form immune complexes that deposit in the glomerular basement membrane (GBM) and mesangium, triggering complement activation (especially C1q, C3, C4 deposition) and causing: 1. Endocapillary and extracapillary proliferation 2. Crescent formation (in Class IV) 3. Progressive renal dysfunction ### Diagnostic & Prognostic Value | Autoantibody | Specificity for SLE | Association with Nephritis | Prognostic Value | | --- | --- | --- | --- | | Anti-dsDNA | Very high (95%) | Very strong | High — flares correlate with activity | | Anti-histone | Low (seen in drug-induced LE) | Weak | Low | | Anti-Ro/SSA | Moderate (40–60% SLE) | Weak | Associated with photosensitivity, neonatal LE | | Anti-centromere | Low in SLE | Very weak | More specific for limited cutaneous systemic sclerosis | **Clinical Pearl:** A rising anti-dsDNA titre with falling complement (C3, C4) is a red flag for impending lupus nephritis flare and warrants intensification of immunosuppression. **Mnemonic:** **dsDNA = Disease-specific, Damage-associated** — think of it as the hallmark marker of active, organ-threatening SLE.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.